Like all medications, GLP injections can have side effects
What factors should clinicians consider when weighing the benefits of prescribing GLP-1 agonists against the potential risks of pancreatitis in patients with a history of this condition
Study methods and models vary by institution and protocol
POSTOPERATIVE MANAGEMENT Management options for recurrent or residual MTC include close observation for indolent disease, surgical resection of locoregional disease, EBRT, and local therapies, such as radiofrequency ablation, cryoablation, and embolization, or systemic therapies, such as conventional chemotherapy, kinase inhibitors, and immune checkpoint inhibitors for non-resectable diseases
Research published in Endocrinology has demonstrated that CRH directly activates mast cells, causing them to degranulate and release histamine and other inflammatory mediators
Patients should track body composition metrics including waist and hip circumference, progress photos, and strength benchmarks (how much weight you can lift for key exercises)